Gene Test May Lead to More Accurate Mesothelioma Diagnosis
| | | | |

Gene Test May Lead to More Accurate Mesothelioma Diagnosis

Could the BRCA-1 associated protein 1 (BAP1) gene offer a more accurate way to identify malignant pleural mesothelioma? New research in Italy suggests that the answer might be yes. Mesothelioma is a cancer that occurs in the cells of the mesothelium, a membrane that surround the lungs and other organs. Because there are also benign conditions that can effect mesothelial cells and cause similar symptoms, mesothelioma is often difficult to identify. To date, there are no definitive biomarkers, though the list of markers that can help with diagnosis and prognosis is growing. In the latest biomarker study, researchers in Italy evaluated BAP1 expression in 266 patients with different mesothelial conditions. A total of 212 patients had mesothelioma, 12 had benign…

New Marker Could Improve Mesothelioma Diagnosis
| |

New Marker Could Improve Mesothelioma Diagnosis

There has been another potential breakthrough in the ongoing worldwide effort to find an effective way to diagnose mesothelioma earlier. Malignant pleural mesothelioma is a fast-growing cancer of the mesothelium.  As with all cancers, early detection can greatly improve the odds of survival.  But because the early symptoms can be mild or mimic other lung diseases, mesothelioma is often not definitively diagnosed until its later stages, when treatment may be less effective. Now, a team of Austrian doctors has identified a cellular protein that they say may be a promising diagnostic marker for mesothelioma. Elevated levels of serum integrin-linked kinase, a protein associated with multiple cellular functions, have already been found in cases of ovarian cancer.  To test its presence in mesothelioma…